Skip Navigation

European Heart Journal 2000 21(5):339-342; doi:10.1053/euhj.1999.1925
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by White, H.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, H.D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

International differences: selection, noise, or real?

H.D. White

Green Lane Hospital, Auckland, New Zealand

References

  1. Barbash GI, Modan M, Goldbourt U, White HD, Van de Werf F. Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: variation by country beyond predictive profile. J Am Coll Cardiol. 1993;21:281–286[Abstract]
  2. Van de Werf F, Topol EJ, Lee KL. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries: results from the GUSTO trial. JAMA. 1995;273:1586–1591[Abstract/Free Full Text]
  3. Holmes DR Jr, Califf RM, Van de Werf F. Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO Trial. Lancet. 1997;349:75–78[CrossRef][Web of Science][Medline]
  4. Aylward PE, Sadowski Z, Granger CB. International differences in outcomes: results from the GUSTO-III trial [abstract]. Circulation. 1997;96:1–202
  5. Akkerhuis KM, Deckers JW, Boersma E. Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes; results from PURSUIT. Eur Heart J. 2000;21:371–381[Abstract/Free Full Text]
  6. Lancet. 1997;349:1429–1435[CrossRef][Web of Science][Medline]
  7. N Engl J Med. 1998;338:1488–1497[Abstract/Free Full Text]
  8. N Engl J Med. 1998;339:436–443[Abstract/Free Full Text]
  9. Hochman JS, Boland J, Sleeper LA. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: results of an international registry. Circulation. 1995;91:873–881[Abstract/Free Full Text]
  10. Rouleau JL, Moyé LA, Pfeffer MA. A comparison of management patterns after acute myocardial infarction in Canada and the United States. N Engl J Med. 1993;328:779–784[Abstract/Free Full Text]
  11. Every NR, Larson EB, Litwin PE. The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med. 1993;329:546–551[Abstract/Free Full Text]
  12. Hochman JS, Sleeper LA, Webb JG. Early revascularization in acute myodcardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625–634[Abstract/Free Full Text]
  13. Ayanian JZ, Hauptman PJ, Guadagnoli E, Antman EM, Pashos CL, McNeil BJ. N Engl J Med. 1994;331:1136–1142[Abstract/Free Full Text]
  14. Nash IS, Nash DB, Fuster V. Do cardiologists do it better? J Am Coll Cardiol. 1997;29:475–478[Abstract]
  15. Jollis JG, DeLong ER, Peterson ED. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med. 1996;335:1880–1887[Abstract/Free Full Text]
  16. Schreiber TL, Elkhatib A, Grines CL, O'Neill WW. Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol. 1995;26:577–582[Abstract]
  17. Barker DJP. Mothers, babies and disease in later life. London: BMJ Publishing; 1994.
  18. Armstrong PW, Fu Y, Chang W-C. Canadian-American differences in management and outcome of non ST elevation acute coronary syndromes: 6 month follow up from the GUSTO IIb Study [abstract]. Circulation. 1998;98:I-479–I-480
  19. Armstrong PW, Fu Y, Chang W-C. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. Circulation. 1998;98:1860–1868[Abstract/Free Full Text]
  20. Fu Y, Chang W-C, Mark D. Impact of on-site interventional facilities on hospital procedures and outcomes: Canada versus the U.S. in GUSTO IIb [abstract]. J Am Coll Cardiol. 1999;33:348A[CrossRef]
  21. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB. Fibrinogen and risk of cardiovascular disease: the Framingham study. JAMA. 1987;258:1183–1186[Abstract/Free Full Text]
  22. Meade TW, Mellows S, Brozovic M. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986;2:533–537[Web of Science][Medline]
  23. Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991;66:351–355[Abstract/Free Full Text]
  24. Eur Heart J. 1993;14:8–17[Abstract/Free Full Text]
  25. Hingorani AD, Liang CF, Fatibene J. A common variant of the endothelial nitric oxide synthase (Glu298->Asp) is a major risk factor for coronary artery disease in the UK. Circulation. 1999;100:1515–1520[Abstract/Free Full Text]
  26. Sane DC, Stump DC, Topol EJ. Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator: increased fibrin(ogen)olysis in blacks. Circulation. 1991;89:170–175
  27. Berkowitz SD, Granger CB, Pieper KS. Incidence and predictors of bleeding after comtemporary thrombolytic therapy for myocardial infarction. Circulation. 1997;95:2508–2516[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
A. B. Greenbaum, R. A. Harrington, M. P. Hudson, C. M. MacAulay, R. G. Wilcox, M. L. Simoons, L. G. Berdan, A. Guerci, D. V. Cokkinos, M. M. Kitt, et al.
Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 492 - 498.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by White, H.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by White, H.D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?